Tandem Diabetes Care, Inc. (TNDM) Stock Overview
Explore Tandem Diabetes Care, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Tandem Diabetes Care, Inc. (TNDM)
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
-24.94
EPS (TTM)
$-1.10
ROE
-0.46%
TNDM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Tandem Diabetes Care, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of TNDM on the NASDAQ shows an RSI of 73.25, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $21.21 for the NASDAQ listing.
Key metrics behind Tandem Diabetes Care, Inc.'s NASDAQ-traded stock include a P/E ratio of -24.94 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TNDM on the NASDAQ.